Esperion Therapeutics
ESPR
#6751
Rank
โ‚น40.38 B
Marketcap
โ‚น204.96
Share price
-3.57%
Change (1 day)
159.00%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of November 2024 (TTM): 1.72

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.39. At the end of 2024 the company had a P/S ratio of 1.51.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.51-48.2%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
9.18 432.53%๐Ÿ‡บ๐Ÿ‡ธ USA
4.58 165.63%๐Ÿ‡บ๐Ÿ‡ธ USA
2.67 54.76%๐Ÿ‡บ๐Ÿ‡ธ USA
6.52 278.01%๐Ÿ‡บ๐Ÿ‡ธ USA
6.88 299.11%๐Ÿ‡บ๐Ÿ‡ธ USA
118 6,754.72%๐Ÿ‡บ๐Ÿ‡ธ USA